Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Fusion Pharmaceuticals Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −3 vs. Q4 2021
- Shares held
- 28.2M
- +550.8K (+2.0%) vs. Q4 2021
- Total value
- $219.1M
- +$103.5M (+89.6%) vs. Q4 2021
- New holders
- 0
- 4 more added
- Sold out
- 3
- 4 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Johnson & Johnson | 3,670,516 | $28.5M | 5.39% | 00.0% | Unchanged |
| FMR LLC | 3,250,832 | $25.3M | 0.00% | +20,866+0.6% | Added |
| OrbiMed Advisors LLC | 3,224,770 | $25.1M | 0.41% | 00.0% | Unchanged |
| Canada Pension Plan Investment Board | 3,116,966 | $24.2M | 0.03% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,055,037 | $23.7M | 0.05% | +1,481,037+94.1% | Added |
| Adams Street Partners LLC | 2,947,809 | $22.9M | 4.24% | 00.0% | Unchanged |
| TPG GP A, LLC | 2,551,794 | $19.8M | 0.25% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $12.4M | 5.88% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,227,017 | $9.53M | 0.20% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 948,327 | $7.37M | 0.19% | 00.0% | Unchanged |
| Artal Group S.A. | 750,000 | $5.83M | 0.25% | 00.0% | Unchanged |
| 1832 Asset Management L.P. | 734,321 | $5.63M | 0.01% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 350,000 | $2.72M | 0.01% | −698,956−66.6% | Reduced |
| Sio Capital Management, LLC | 259,763 | $2.02M | 0.81% | 00.0% | Unchanged |
| Victory Capital Management Inc | 183,690 | $1.30M | 0.00% | −66,690−26.6% | Reduced |
| Morgan Stanley | 103,982 | $808.0K | 0.00% | +26,373+34.0% | Added |
| Sofinnova Investments, Inc. | 78,066 | $607.0K | 0.05% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 43,394 | $337.0K | 0.01% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 38,198 | $297.0K | 0.05% | 00.0% | Unchanged |
| Woodline Partners LP | 25,703 | $200.0K | 0.00% | −217,637−89.4% | Reduced |
| Geode Capital Management, LLC | 25,136 | $195.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 21,300 | $165.0K | 0.00% | +21,253+45,219.1% | Added |
| BlackRock Inc. | 8,253 | $64.0K | 0.00% | −1,300−13.6% | Reduced |
| JPMorgan Chase & Co | 4,352 | $34.0K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 875 | $7.16K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 850 | $7.00K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 300 | $2.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 30 | $233 | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,160−100.0% | Sold out |
| AlphaCentric Advisors LLC | – | – | – | – | Not filed |